HISTOGENICS CORP Sales Agreements

4 Contracts & Agreements
Recent Contracts
Category
Company
Industry
Jur. Jurisdiction
Filed
Controlled Equity OfferingSM Sales Agreement, dated May 8, 2020, by and between Ocugen, Inc. and Cantor Fitzgerald & Co
Sales Agreements
HISTOGENICS CORP
Biotechnology
NY
2020
At Market Issuance Sales Agreement, dated June 10, 2022, by and among Ocugen, Inc., Cantor Fitzgerald & Co., Mizuho Securities USA LLC, H.C. Wainwright & Co., LLC, Roth Capital...
Sales Agreements
HISTOGENICS CORP
Biotechnology
NY
2022
At Market Issuance Sales Agreement, dated August 14, 2020, by and among Ocugen, Inc., Cantor Fitzgerald & Co. and Oppenheimer & Co. Inc
Sales Agreements
HISTOGENICS CORP
Biotechnology
NY
2020
Controlled Equity OfferingSM Sales Agreement, dated June 12, 2020, by and between Ocugen, Inc. and Cantor Fitzgerald & Co
Sales Agreements
HISTOGENICS CORP
Biotechnology
NY
2020